Lady Vulpix
7th December 2011, 12:42 PM
Latest news in Spanish (http://www.neoteo.com/cuba-registro-una-vacuna-contra-el-cancer)
Somewhat less recent news in English (http://www.huffingtonpost.com/2011/09/08/cimavax-egf-cuba-announce_n_954630.html)
Brief summary: the drug is called CIMAVax-EGF and was developed by the Cuban Molecular Immunology Center "Centro de Inmunología Molecular (CIM)". It does not prevent nor cure lung cancer but, according to the latest studies, it can turn this otherwise lethal disease, even at advanced stages, into a controllable, non-lethal chronic disease. That is, patients suffering from advanced lung cancer may be able to survive and keep the disease at bay for as long as they continue the treatment.
Clinical tests on human patients began in 1995, and so far no serious collateral effects have been observed.
CIMAVax-EGF has already been patented in Cuba and Peru, and is in process of being registered in Brazil, Argentina, Colombia and other countries.
Somewhat less recent news in English (http://www.huffingtonpost.com/2011/09/08/cimavax-egf-cuba-announce_n_954630.html)
Brief summary: the drug is called CIMAVax-EGF and was developed by the Cuban Molecular Immunology Center "Centro de Inmunología Molecular (CIM)". It does not prevent nor cure lung cancer but, according to the latest studies, it can turn this otherwise lethal disease, even at advanced stages, into a controllable, non-lethal chronic disease. That is, patients suffering from advanced lung cancer may be able to survive and keep the disease at bay for as long as they continue the treatment.
Clinical tests on human patients began in 1995, and so far no serious collateral effects have been observed.
CIMAVax-EGF has already been patented in Cuba and Peru, and is in process of being registered in Brazil, Argentina, Colombia and other countries.